Matches in Wikidata for { <http://www.wikidata.org/entity/Q74278341> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q74278341 description "clinical trial" @default.
- Q74278341 description "ensayu clínicu" @default.
- Q74278341 description "klinisch onderzoek" @default.
- Q74278341 description "клінічне випробування" @default.
- Q74278341 name "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)" @default.
- Q74278341 name "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer" @default.
- Q74278341 type Item @default.
- Q74278341 label "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)" @default.
- Q74278341 label "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer" @default.
- Q74278341 prefLabel "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)" @default.
- Q74278341 prefLabel "Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer" @default.
- Q74278341 P1050 Q74278341-A5E77A3B-CB31-40A6-903F-E4C2BDD9CE48 @default.
- Q74278341 P1132 Q74278341-955EDD63-2EA0-4039-AE57-76C0FF51EDB0 @default.
- Q74278341 P1476 Q74278341-9E0756FF-5BEB-4AC9-B40E-5B2067D9FF26 @default.
- Q74278341 P17 Q74278341-DE67BE97-8B68-4402-911D-329F520503AE @default.
- Q74278341 P2899 Q74278341-FA4C4589-7BE7-4771-8A3E-C53FDB137787 @default.
- Q74278341 P3098 Q74278341-942DC2DD-7077-4298-A8BC-84BFD3922F2D @default.
- Q74278341 P31 Q74278341-E0589A24-9537-4410-9A57-8C37CD2DDC67 @default.
- Q74278341 P4135 Q74278341-D7B1FD92-6CAB-4B9E-A8F9-AC9780FD064C @default.
- Q74278341 P580 Q74278341-E973BAF8-A01D-41FC-BB4D-4116A4425FEF @default.
- Q74278341 P582 Q74278341-24817F77-6A92-42DD-AD91-122079C3BF8B @default.
- Q74278341 P6099 Q74278341-BE1F194B-A615-47BA-8EDF-B3B9C8144FAA @default.
- Q74278341 P767 Q74278341-CA5B89A4-72F1-4137-BC8C-15555D5AB31B @default.
- Q74278341 P8363 Q74278341-E111E63D-0C3B-4AD3-B3D9-1AD6A1BE2C08 @default.
- Q74278341 P921 Q74278341-0D178B03-3155-4D43-96D7-E36DB8DC0459 @default.
- Q74278341 P1050 Q33525 @default.
- Q74278341 P1132 "+50" @default.
- Q74278341 P1476 "Tisch Cancer Institute - BMS Study # CA027-005: Neoadjuvant Nivolumab + BMS-813160 (CCR2/5-inhibitor) or BMS-986253 (Anti-IL-8) for NSCLC or HCC" @default.
- Q74278341 P17 Q30 @default.
- Q74278341 P2899 "+18" @default.
- Q74278341 P3098 "NCT04123379" @default.
- Q74278341 P31 Q30612 @default.
- Q74278341 P4135 "+99" @default.
- Q74278341 P580 "2019-11-01T00:00:00Z" @default.
- Q74278341 P582 "2020-10-31T00:00:00Z" @default.
- Q74278341 P6099 Q42824440 @default.
- Q74278341 P767 Q266423 @default.
- Q74278341 P8363 Q78089383 @default.
- Q74278341 P921 Q7041828 @default.